Guild Learning and Development, together with Novo Nordisk, has developed a new online module, ‘IDegAsp – a co-formulation insulin’.
The module consists of three short webinars, and focuses on the insulin formulation – its properties, safety and efficacy.
IDegAsp is available in Australia as Ryzodeg and comprises the ultra-long acting insulin, degludec, with the rapid-acting insulin, aspart, in one injection.
This learning activity has been accredited for one hour of Group 1 CPD (or 1 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to one hour of Group 2 CPD (or 2 CPD credits) upon successful completion of relevant assessment activities.
To enrol in this course, please visit: guilded.guild.org.au
Please contact Guild Learning and Development on 1800 049 056 or email learninganddevelopment@guild.org.au for more information.
